SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
La Jolla Pharmaceutical Co.’s stock surged by more than 17 percent last week, spurred by director Kevin Tang’s purchase of 53,836 shares last Tuesday.
Palomar Health’s Board of Directors voted June 24 to close Palomar Health Downtown Hospital in Escondido.
La Jolla-based Avalon Ventures led a $17 million Series A round for Ankasa Regenerative Therapeutics, handing over $8.5 million of the funding to the upstart biotech working on new tech for reactivating stem cells and tissue regeneration.
BIOTECH: Current Scanners Cumbersome Costly and Overbooked
Local startup JAS Neuro Imaging has forged a partnership with Maryland-based Brain Biosciences to bring breakthrough brain technology directly to the doctor’s office.
The Sanford-Burnham Medical Research Institute has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.
Celladon Corp. announced that it will suspend all research and development activities.
BIOTECH: Hybritech’s Story Is First Chapter of S.D.’s Biotech Biography
The name Hybritech is pinned to local resumes like a badge of honor, as if to say, “I was here in the beginning.”
OncoSec Medical Inc., a company developing cancer immunotherapies, announced Thursday the appointment of Richard B. Slansky as chief financial officer effective July 6.
Palomar Health's Board of Directors voted Wednesday night to close Palomar Health Downtown Hospital in Escondido.
San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced Wednesday that it entered into a definitive $6 million stock purchase agreement.
ARK Animal Health Inc., a wholly-owned subsidiary of San Diego-based Sorrento Therapeutics Inc., was granted a Minor Use/Minor Species (MUMS) Drug Designation for its pain drug, ARK-001, for dogs with bone cancer.
The Sanford-Burnham Medical Research Institute announced Wednesday that it has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.
Imprimis Pharmaceuticals Inc. has acquired the rights to novel sedation and analgesia/anesthesia formulations that can block pain and sedate patients undergoing ocular and other surgical procedures.
San Diego’s AMN Healthcare Services, the country’s largest provider of health care staffing services, has won a sole source contract with Premier Inc. to offer staffing services and workforce solutions to its alliance of about 3,400 hospitals and 110,000 other health care facilities.
Ambrx Inc., a San-Diego based biotechnology company, has named Tiecheng (Alex) Qiao its CEO effective immediately.